Aurora Cannabis Inc's stock has seen a modest uptick this week, alongside significant company developments.
Aurora Cannabis Inc (ACB.TO) closed at C$3.88 on Monday, reflecting a 2.02% decline for the day but a 2.92% increase over the past week. Recent headlines highlight the company's achievements, including record annual revenue and strategic certifications that could bolster its market position.
Advertisement
Aurora Cannabis Inc
ACB.TO
ACB.TO
Aurora Cannabis Inc
WealthAwesomeMarket cap
$342.51M
52W high
$9.33
52W low
$3.59
1W change
+5.87%
Beta
1.34
Analyst Price Targets
Based on analyst covering ACB
Wall Street analysts forecast ACB stock price to fall 0.6% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.38
-0.6% Upside
Current Price
C$5.41
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ACB's historical volatility
30-Day Vol
73.0%
Annualized
90-Day Vol
61.7%
Annualized
Trend (90d)
+49.4%
Annualized drift
90d Mean
C$6.45
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$5.74 | C$4.46 โ C$7.38 |
| 60 trading days | C$6.08 | C$4.26 โ C$8.69 |
| 90 trading days | C$6.45 | C$4.17 โ C$9.98 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider Aurora's recent performance amidst its broader market challenges, particularly as it navigates a competitive landscape in the cannabis sector. The company's recent announcements may provide a glimpse of potential growth opportunities.
Aurora Cannabis Reports Record Annual Revenue of C$288.6 Million
The company's achievement of C$288.6 million in global medical cannabis net revenue underscores its growth potential, yet the negative profit margin of -42.4% remains a critical challenge.
Bull case
Aurora's record annual revenue of C$288.6 million and adjusted EBITDA of C$53.8 million for fiscal 2026 show strong operational performance. This could boost investor confidence moving forward.
Bear case
Despite the positive revenue figures, Aurora's ongoing negative profit margins and significant year-to-date losses of 34.68% raise concerns about its financial health and sustainability in a competitive market.
Recent Price Action
Aurora Cannabis Inc's stock closed at C$3.88 on Monday, down 2.02% for the day. However, the stock has seen a 2.92% increase over the past week, suggesting some recovery after earlier declines. Year-to-date, the stock remains down by 34.68%, reflecting ongoing challenges in the cannabis market.
Company News and Developments
Advertisement
This week, Aurora Cannabis announced record annual revenue and adjusted EBITDA for fiscal 2026, achieving C$288.6 million in global medical cannabis net revenue and C$53.8 million in adjusted EBITDA. These results may reflect the company's operational strength in a challenging market. Additionally, Aurora's subsidiary, Safari Flower Company, received EU-GMP certification for its Niagara facility, enhancing its capacity for international sales. Institutional Shareholder Services Inc. has also recommended that shareholders support all resolutions at the upcoming 2026 Annual General Meeting.
Technical Picture
From a technical standpoint, Aurora Cannabis is currently trading below its 50-day moving average of C$4.19 and its 200-day moving average of C$5.24, indicating a bearish trend. The stock is within a 52-week range of C$3.59 to C$9.33, currently positioned at approximately 5% of this range. With a beta of 1.35, the stock exhibits higher volatility compared to the market. The current trading volume stands at 196,103 shares, which is below the 20-day average volume of 288,129 shares, suggesting lower investor interest at this time.
Insider Activity
No recent insider trading activity has been reported for Aurora Cannabis, indicating a potential lack of insider confidence or strategic movements at this time.
Price Action Summary
Aurora Cannabis Inc closed at C$3.88, reflecting a 1-day decline of 2.02%. While the stock has seen a slight recovery over the past week, ongoing challenges in profitability and market conditions remain key considerations for investors.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
